<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04281784</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00007031-A</org_study_id>
    <secondary_id>1R01AG006244</secondary_id>
    <nct_id>NCT04281784</nct_id>
  </id_info>
  <brief_title>Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)</brief_title>
  <acronym>PICSI-H</acronym>
  <official_title>Using the Electronic Health Record to Identify and Promote Goals-of-Care Communication for Older Patients With Serious Illness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this protocol is to test the effectiveness of a Jumpstart intervention on
      patient-centered outcomes for patients with chronic illness by ensuring that they receive
      care that is concordant with their goals over time, and across settings and providers. This
      study will examine the effect of the EHR-based intervention to improve quality of palliative
      care for patients over the age of 65 with chronic, life-limiting illness with a particular
      emphasis on Alzheimer's disease and related dementias (ADRD). The specific aims are: 1) to
      evaluate the effectiveness of a novel EHR-based (electronic health record) clinician
      Jumpstart guide, compared with usual care, for improving the quality of care; the primary
      outcome is documentation of a goals-of-care discussion during the hospitalization. Secondary
      outcomes focus on intensity of care: ICU use, ICU and hospital length of stay, costs of care
      during the hospitalization, and 30-day hospital readmissions; and 2) to conduct a
      mixed-methods evaluation of the implementation of the Jumpstart intervention, guided by the
      RE-AIM and CFIR frameworks for implementation science, incorporating quantitative assessments
      of effectiveness, implementation and maintenance and qualitative assessments of clinician
      perspectives on barriers and facilitators to future implementation and dissemination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OVERVIEW: This is a large pragmatic trial of the Jumpstart intervention designed to promote
      goals-of-care discussions for older, seriously ill, hospitalized patients. The trial recruits
      consecutively eligible patients from three UW Medicine hospitals. The Jumpstart Guide is a
      communication-priming intervention that addresses hospitalized patients' goals of care. It
      includes information, drawn from the electronic health record (EHR), identifying the dates
      and locations of prior advance care planning documents (e.g. living wills, healthcare
      directives, durable power of attorney for healthcare, and Physician Orders for Life
      Sustaining Treatments (POLST)). This information is provided by email and in-person to
      patients' clinicians. The Jumpstart Guide includes tips to improve this communication. The
      trial will assess the effectiveness of the EHR-based clinician Jumpstart as compared with
      usual care.

      SPECIFIC AIM (Trial 1): Evaluate the EHR-based clinician Jumpstart compared to usual care.

      Intervention. Step 1- Subject Identification/Recruitment/Randomization: The investigators
      will use automated methods with EHR data, including natural language processing/machine
      learning (NLP/ML) approaches, to identify hospitalized patients with serious illness during
      the first 2-3 days of this specific admission. Screening reports will be produced daily and
      include all likely eligible patients. Study staff will use these daily screening reports to
      review individual records of eligible patients for inclusion and exclusion criteria (i.e.
      verify eligibility). Patients will not be approached for consent. Eligible patients will be
      assigned to intervention or comparator in a 1:1 ratio. Patients are randomized using variable
      size blocks and stratified for hospital and ADRD vs. no ADRD.

      Step 2- EHR-based Clinician Jumpstart Guide: The Jumpstart guide is developed by applying
      NLP/ML algorithms to both inpatient and outpatient EHR notes (e.g., progress notes, specialty
      consult notes, alerts and care plans) preceding the current hospitalization. It summarizes
      the presence/absence patients' prior goals-of care discussions and the presence/absence of
      POLST, advance directives and DPOA (durable power of attorney) documentation. It also
      provides general recommendations to initiating goals of care discussions. Jumpstart guides
      are prepared for the intervention group only.

      Step 3- Delivery of the intervention: For the intervention group, the investigators deliver
      the Jumpstart guide to the primary hospital team (all attending and resident physicians and
      advanced practice providers) via secure email, or in person delivery. The Jumpstart guides
      are delivered within 1 business day of patient randomization. Study staff monitor the care
      team of the patient, and if there are any changes, ensure that any new providers receive the
      Jumpstart guide as well.

      Comparator: The hospital teams for patients in the control group do not receive Jumpstart
      guides.

      Outcome Assessment. Outcomes are obtained from the EHR and use, in part, NLP/ML methods. The
      primary outcome is EHR documentation of goals-of-care discussions in the 30 days following
      randomization. Secondary outcomes are measures of intensity of care, including utilization
      metrics (i.e., ICU admissions, ICU and hospital lengths of stay, 30-day hospital
      readmissions), costs of care during hospital admission, and estimated costs of implementing
      the intervention.

      SPECIFIC AIM (Trial 1): Evaluate implementation of the Jumpstart Guide and identify barriers
      and facilitators to future implementation.

      Clinician recruitment: Study staff will recruit clinicians who were involved with the study
      to participate in a short interview after the clinician's study involvement with the enrolled
      patient has ended. Clinician participants will be selected using purposive sampling to ensure
      a diverse group (e.g., age, race/ethnicity, gender, specialty, year of training).

      Interview: Using an interview guide developed specifically for this project, interviewers
      will assess respondents' experience with the intervention and gather suggestions for ways to
      improve the intervention's content, delivery and implementation, including implementation
      outcomes (e.g., acceptability, fidelity, penetration, maintenance) that will guide future
      dissemination of the intervention.

      Assessment: Interviews are audio recorded, transcribed, and analyzed using thematic analytic
      methods. To ensure trustworthiness, interviewers will perform a &quot;member check&quot; of the results
      with a subset of participants selected for diversity of participant type.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EHR documentation of Goals of Care discussions</measure>
    <time_frame>Assessed for the period between randomization and 30 days following randomization</time_frame>
    <description>The primary outcome is the proportion of patients who have a goals-of-care (GOC) discussion that has been documented in the EHR in the period between randomization and 30 days following randomization The proportion is the number of patients with GOC documentation over the number of patients in each study arm. Documentation of goals-of-care discussions will be evaluated using our NLP/ML methods. Study staff will manually review and compare findings using a randomly-selected sample of charts using our standard EHR abstraction methods; manual chart abstraction will be the gold standard.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensity of care/ICU use: ICU admissions</measure>
    <time_frame>Assessed for the period between randomization and 30 days following randomization</time_frame>
    <description>Secondary outcomes include measures of intensity of care, including utilization metrics: Number of ICU admissions during the patient's (index) hospital stay will be collected from the EHR using our automated and validated methods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of care/ICU use: ICU length of stay</measure>
    <time_frame>Assessed for the period between randomization and 30 days following randomization</time_frame>
    <description>Secondary outcomes include measures of intensity of care, including utilization metrics: Number of days the patient spent in the ICU during their (index) hospital stay will be collected from the EHR using our automated and validated methods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of care/Hospital use: Hospital length of stay</measure>
    <time_frame>Assessed for the period between randomization and 30 days following randomization</time_frame>
    <description>Secondary outcomes include measures of intensity of care, including utilization metrics: Number of days the patient spent in the hospital during that (index) hospital stay will be collected from the EHR using our automated and validated methods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of care: Hospital Readmissions 30 days</measure>
    <time_frame>Assessed for the period between randomization and 30 days following randomization</time_frame>
    <description>Secondary outcomes include measures of intensity of care, including utilization metrics: Number of hospital readmissions between randomization and 30 days following randomization will be collected from the EHR using our automated and validated methods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of care: ICU Readmissions 30 days</measure>
    <time_frame>Assessed for the period between randomization and 30 days following randomization</time_frame>
    <description>Secondary outcomes include measures of intensity of care, including utilization metrics: Number of ICU readmissions between randomization and 30 days following randomization will be collected from the EHR using our automated and validated methods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of care: Healthcare costs</measure>
    <time_frame>1 and 3 months after randomization</time_frame>
    <description>Costs for intervention vs. control will be reported in US dollars and identified from UW Medicine administrative financial databases. Costs will be reported for total hospital costs and disaggregated costs (direct-variable, direct fixed, indirect costs). Direct-variable costs will include supply and drug costs. Direct-fixed costs will include labor, clinical department administration, and overhead fees. Indirect costs represent services provided by cost centers not directly linked to patient care such as information technology and environmental services. Costs for ED (emergency department) days and ICU days will be similarly assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality at 1 year (safety outcome)</measure>
    <time_frame>1 year after randomization</time_frame>
    <description>From Washington State death certificates.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Key Implementation Factors</measure>
    <time_frame>3 months after randomization</time_frame>
    <description>Qualitative interviews after individual participation. Interviews will be guided by the RE-AIM and Consolidated Framework for Implementation Research (CFIR) to explore the factors associated with implementation (e.g., reach, maintenance, feasibility, inner and outer settings, individuals, and processes of care.) Individual constructs within these domains were chosen to fit this specific intervention and context.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Dementia</condition>
  <condition>Chronic Disease</condition>
  <condition>Neoplasm Metastasis</condition>
  <condition>Lung Neoplasm</condition>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <condition>Heart Failureï¼ŒCongestive</condition>
  <condition>Liver Cirrhosis</condition>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Lung Diseases, Interstitial</condition>
  <condition>Peripheral Vascular Disease</condition>
  <condition>Diabetes With End Organ Injury</condition>
  <condition>Palliative Care, Patient Care</condition>
  <condition>Health Care Quality, Access, and Evaluation</condition>
  <condition>Patient Care</condition>
  <condition>Inpatients</condition>
  <condition>Health Communication</condition>
  <condition>Patient Care Planning</condition>
  <arm_group>
    <arm_group_label>EHR-based Clinician Jumpstart</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Jumpstart Guide will be developed by extracting data from the EHR using automated methods and NLP/ML algorithms with both inpatient and outpatient notes (e.g., progress notes, specialty consult notes, alerts and care plans) preceding the current hospitalization. It will summarize the presence/absence of POLST, advance directives and DPOA documentation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The clinicians (hospital teams) for patients in the control group will not receive Jumpstart guides. These subjects will receive usual care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>EHR-based Clinician Jumpstart</intervention_name>
    <description>The Jumpstart Guide is a communication-priming intervention for clinicians that addresses hospitalized patients' goals of care. The intervention's goal is to prompt clinicians to provide standard of care which includes a discussion with patients or their legal surrogate decision-maker about their goals of care. The one-page Jumpstart Guide provides information to the clinician about prior advance care planning documentation derived from the EHR. The Jumpstart Guides includes tips to improve goals-of-care communication.</description>
    <arm_group_label>EHR-based Clinician Jumpstart</arm_group_label>
    <other_name>Jumpstart Guide Intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligibility criteria apply to two subject groups: 1) seriously ill adult patients; 2)
        hospital clinicians.

        Inclusion Criteria:

          -  PATIENTS. Eligible patients will be those who are: 1) older than 80 years of age; or
             2) 55 years of age or older who meet criteria for serious illness. Serious illness
             encompasses acute illness (e.g. COVID-19) and chronic illnesses (e.g. those included
             in the Dartmouth Atlas to study end-of-life care: malignant cancer/leukemia, chronic
             pulmonary disease, coronary artery disease, heart failure, chronic liver disease,
             chronic renal disease, dementia, diabetes with end-organ damage, and peripheral
             vascular disease).

          -  CLINICIANS (Interview). Eligible clinicians will be those who are 18 years of age or
             older, English-speaking, employed at a participating hospital, and have been the
             clinician of record for an enrolled patient in the trial.

        Exclusion Criteria:

          -  Reasons for exclusion for any patient include: restricted status (prisoners or victims
             of violence); legal or risk management concerns (as determined by the attending
             physician or via hospital record designation).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. Randall Curtis, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>J. Randall Curtis, MD, MPH</last_name>
    <phone>206-744-3356</phone>
    <email>jrc@uw.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruth A. Engelberg, PhD</last_name>
    <phone>206-744-9523</phone>
    <email>rengel@uw.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Randall Curtis, MD, MPH</last_name>
      <phone>206-744-3356</phone>
      <email>jrc@uw.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UW Medical Center - Northwest</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Randall Curtis, MD, MPH</last_name>
      <phone>206-744-3356</phone>
      <email>jrc@uw.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UW Medical Center - Montlake (UWMC)</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Randall Curtis, MD, MPH</last_name>
      <phone>206-744-3356</phone>
      <email>jrc@uw.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 19, 2020</study_first_submitted>
  <study_first_submitted_qc>February 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2020</study_first_posted>
  <last_update_submitted>July 11, 2020</last_update_submitted>
  <last_update_submitted_qc>July 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>J. Randall Curtis</investigator_full_name>
    <investigator_title>Professor, Department of Medicine, SOM: Department of Medicine: Pulmonary, Critical Care and Sleep Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

